Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SAFE-Trial: Safe Surgery for Glioblastoma Multiforme: Awake Craniotomy Versus Surgery Under General Anesthesia. A Multicenter Prospective Randomised Controlled Study

NCT03861299 is registered in ClinicalTrials.gov with Jasper Gerritsen as lead sponsor.

NCT NCT03861299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03861299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SAFE-Trial: Safe Surgery for Glioblastoma Multiforme: Awake Craniotomy Versus Surgery Under General Anesthesia. A Multicenter Prospective Randomised Controlled Study
Lead sponsor
Jasper Gerritsen
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2019
Completion date
September 1, 2027
Enrollment
246 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, grade iv, brain cancer, brain neoplasms, brain tumor, glioblastoma, glioblastoma multiforme, glioblastoma multiforme of brain